Robert Kadlec's most recent trade in MiNK Therapeutics Inc was a trade of 1,883 Common Stock done at an average price of $7.2 . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MiNK Therapeutics Inc | Robert Peter Kadlec | Director | Grant, award, or other acquisition of securities at price $ 7.17 per share. | 02 Jun 2025 | 1,883 | 4,647 | - | 7.2 | 13,501 | Common Stock |
| MiNK Therapeutics Inc | Robert Peter Kadlec | Director | Grant, award, or other acquisition of securities at price $ 8.79 per share. | 03 Mar 2025 | 1,536 | 2,764 | - | 8.8 | 13,501 | Common Stock |
| MiNK Therapeutics Inc | Robert Kadlec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2024 | 41,745 | 41,745 | - | - | Stock Option | |
| MiNK Therapeutics Inc | Robert Kadlec | Director | Grant, award, or other acquisition of securities at price $ 0.73 per share. | 30 Oct 2024 | 12,286 | 12,286 | - | 0.7 | 8,969 | Common Stock |